Agape ATP Corp (ATPC): Price/Earnings to Growth Multiple

Symbol and logo of brand Agape ATP Corp. (ATPC)

Trading staff rotation creates certain risks, which the PEG fundamental indicator visualizes for Agape ATP Corporation (ATPC). The value of 0.00 captures the current magnitude of the indicator, confirming growth potential. Stability is ensured by recruiting specialized wellness and logistics experts. The expansion of personalized medicine and digital health services in Southeast Asia serves as an additional stimulus, expanding the client base.

ATPC Agape ATP Corporation Price/Earnings to Growth Multiple (02/21/2024 - 11/13/2026)

Analytical breakdowns for Agape ATP Corporation (ATPC)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
Fundamental company analysis:ATPC - Agape ATP Corp
Signature product of agapeatpgroup.com

The selection of promising issuers is based on a comparison of market value and profit dynamics. The PEG ratio is calculated by dividing the P/E ratio by the net income growth rate to determine whether current quotes are fair. For Agape ATP Corporation (ATPC), this calculation is limited by the specifics of the Malaysian dietary supplement market and the absence of unique biotechnologies. Values below one signal that the asset is undervalued. The PEG ratio trend helps verify capitalization potential.

Competitors of Agape ATP Corporation

ASND (Ascendis Pharma AS) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Madrigal Pharma MDGL|CORT - Price/Earnings to Growth Multiple|Rhythm Pharmaceuticals - PEG Multiple|Price to Earnings Adjusted for Growth Rate akerotx.com|MTSR (Metsera) - Price/Earnings to Growth Multiple|MLTX: Company Value to Earnings Growth Ratio|CRNX (Crinetics Pharma) - PEG Multiple|PEG Multiple NewAmsterdam Pharma Corp|PEG Multiple SLNO|Price/Earnings to Growth Ratio FOLD (amicusrx.com)|Price/Earnings to Growth Ratio 89bio ETNB|Agios (AGIO) - Price to Earnings Adjusted for Growth Rate|GPCR - Price/Earnings to Growth Ratio|MDXG: Price/Earnings to Growth Ratio|RZLT: PEG Multiple|LXRX - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio MBX Biosciences|Altimmune Inc (ALT) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Aardvark Therapeutics Corp (AARD)|Price/Earnings to Growth Multiple Sagimet Biosciences Inc SGMT|PEG Multiple BIOA (BioAge Labs, Inc.)|PEG Multiple biomeafusion.com BMEA|Quince - PEG Multiple|Price to Net Income Growth Ratio Fractyl Health Inc. (GUTS)|VTVT: PEG Multiple|Pluri (PLUR) - PEG Multiple|Price/Earnings to Growth Ratio Synlogic Inc.|lipocine.com - Market Cap to Earnings and Growth Ratio|PEG Multiple MTNB|SPRB - Price to Earnings Adjusted for Growth Rate|Galecto Corp - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio CTCX|Lumos Pharma, Inc. - PEG Multiple|ONVO - PEG Multiple|RDUS (Radius Recycling) - Price/Earnings to Growth Multiple